PharmD Info

A forum for Indian Pharmacy Professionals

An Inter-professional learning platform for the healthcare professionals to discuss on various health care topics with pharmacy professionals.
Forum rules: The contents of the pharmdinfo.com, such as text, graphics, images, and other material contained on the pharmdinfo.com Site ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Pharmdinfo.com Site!

If you think you may have a medical emergency, call your doctor or 108 immediately. pharmdinfo.com does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site
  • User avatar
#335
US regulators have green-lighted the use of Impax’ Zomig to treat migraine in patients aged 12 years and older, marking approval of the first nasally-delivered prescription medicine for this age group.
The US Food Administration’s nod is for the treatment of acute migraine with or without aura, offering an alternative method of delivery that is particularly useful for those who experience related nausea or are unable to take an oral formulation.
Zomig (zolmitriptan) Nasal Spray was first approved in the US for adults with acute migraine in September 2003. Paediatric clearance is based on clinical data showing that the spray is significantly more effective in addressing symptoms of migraine than a placebo, with a similar safety profile to that seen in adults, the firm said. The one-year prevalence of migraine among US children aged 12 to 19 is estimated by the American Migraine Prevalence and Prevention Study to be around 6.3%, and treatment options for this age group remain limited.
Similar Topics
Topics Statistics Last post
0 Replies 
1532 Views
by Prajith
24 Oct 2015, 10:40
0 Replies 
3826 Views
by Admin
30 Jul 2018, 11:37
0 Replies 
1304 Views
by Prajith
04 Jun 2016, 09:19
0 Replies 
1178 Views
by Prajith
28 Nov 2015, 10:53
1 Replies 
369 Views
by Subbaiah.kn
11 Mar 2020, 12:28

Thanks for the post

Good to know about these guidelines. But how we en[…]

Dear Delegate, Warm Greetings from *NATIONAL FORU[…]

University Grants Commission (Open and Distance Le[…]

E-Learn Portal